Erlotinib Active Not Recruiting Phase 2 Trials for Stage IV Lung Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01556191Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR